Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses

Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses

Fraunhofer IPA and LMU Medical Center Unveil Robotic Assistance System for Pediatric Medicine

Fraunhofer IPA and LMU Medical Center Unveil Robotic Assistance System for Pediatric Medicine

Tailor-made functionalized gelatin – manufactured with reproducible results

Tailor-made functionalized gelatin – manufactured with reproducible results

AI agent MIRA supports clinical workflows in electronic health records as a co-pilot

AI agent MIRA supports clinical workflows in electronic health records as a co-pilot

VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on June 11, 2026

VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on June 11, 2026

Complications after liver transplantation and leukemic niches: Heidelberg Faculty of Medicine honors outstanding early-career researchers

Complications after liver transplantation and leukemic niches: Heidelberg Faculty of Medicine honors outstanding early-career researchers

AI Diagnoses Brain Tumors in Minutes Instead of Weeks

AI Diagnoses Brain Tumors in Minutes Instead of Weeks

CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice

CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice

Fat hack protects against cell death

Fat hack protects against cell death